Nurix Therapeutics, Inc. (NRIX) vs Precigen, Inc. (PGEN)
- Nurix Therapeutics, Inc. NRIX 24.42 −2.12%
- Precigen, Inc. PGEN 6.35 −11.81%
Nurix Therapeutics, Inc. and Precigen, Inc. are both Biotechnology companies. Nurix Therapeutics, Inc. and Precigen, Inc. are of similar size ($2.7B and $2.6B). Precigen, Inc. has negative trailing earnings, so its P/E is not meaningful; Nurix Therapeutics, Inc. trades at 9.7×. Precigen, Inc. grew revenue faster over the last twelve months: 1,875.1% against 738.8%. Nurix Therapeutics, Inc. has the higher net margin (42.0% vs −392.8%) and the higher return on invested capital (0.00% vs −24.9%). Across the 18 metrics below, Nurix Therapeutics, Inc. leads on 16 and Precigen, Inc. on 2.
Valuation
Profitability
| Metric | NRIX | PGEN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 90.67% | 65.16% |
| Operating margin | 41.27% | (46.08%) | 0.00% |
| Net margin | 42.01% | (392.81%) | 0.00% |
| Free cash flow margin | 52.68% | (134.42%) | 0.00% |
| Return on equity | 43.99% | (9,907.46%) | (56.36%) |
| Return on assets | 34.33% | (247.40%) | (48.04%) |
| Return on invested capital | 0.00% | (24.87%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack